Additional file 1: of ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals
Chi-Ping Huang
Jinbo Chen
Chi-Cheng Chen
Guodong Liu
Yong Zhang
Edward Messing
Shuyuan Yeh
Chawnshang Chang
10.6084/m9.figshare.8318807.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_ASC-J9_increases_the_bladder_cancer_chemotherapy_efficacy_via_altering_the_androgen_receptor_AR_and_NF-_B_survival_signals/8318807
Figure S1. The illustration of xenografts and timeline of treatment regimen with Cisplatin (Cis) and ASC-J9® (ASC). Red arrows = ASC, black arrows = Cis. (PDF 84 kb)
2019-06-24 05:00:00
Bladder cancer
Androgen receptor
NF-κB
ASC-J9®
Cisplatin